Provided by Tiger Trade Technology Pte. Ltd.

Harrow Health Inc

30.62
+0.27000.89%
Post-market: 30.970.3500+1.14%18:58 EDT
Volume:708.52K
Turnover:21.65M
Market Cap:1.15B
PE:-30.64
High:31.11
Open:30.09
Low:29.90
Close:30.35
52wk High:54.85
52wk Low:28.54
Shares:37.49M
Float Shares:28.93M
Volume Ratio:1.32
T/O Rate:2.45%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9993
EPS(LYR):-0.1400
ROE:-116.07%
ROA:-0.45%
PB:75.52
PE(LYR):-218.71

Loading ...

Harrow Stock Tumbles on Weaker 1Q Revenue, Wider Loss

Dow Jones
·
May 12

Stock Track | Harrow Health Plummets 13.26% in Pre-Market on Disappointing Q1 Earnings and Revenue Miss

Stock Track
·
May 12

Stock Track | Harrow Health Plunges 11.41% in Pre-Market on Disappointing Q1 Earnings and Revenue Miss

Stock Track
·
May 12

Stock Track | Harrow Health Plunges 10.62% Post-Market on Q1 Revenue and Earnings Miss

Stock Track
·
May 12

Harrow Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 12

Harrow reports Q1 EPS (74c) vs. (50c) last year

TIPRANKS
·
May 12

Harrow Q1 Loss Widens, Revenue Falls; Shares Drop After-Hours

MT Newswires Live
·
May 12

Stock Track | Harrow Health Plunges 7.99% After Hours on Q1 Earnings Miss and Widened Loss

Stock Track
·
May 12

Harrow Q1 revenue misses analyst estimates

Reuters
·
May 12

Harrow Q1 EPS $(0.74) Misses $(0.39) Estimate, Sales $44.203M Miss $52.420M Estimate

Benzinga Earnings
·
May 12

Harrow Inc Q1 Gross Margin 61%

THOMSON REUTERS
·
May 12

Harrow Inc Q1 EPS USD -0.74

THOMSON REUTERS
·
May 12

Harrow Announces First Quarter 2026 Financial Results

THOMSON REUTERS
·
May 12

Earning Preview: Harrow Health Inc revenue is expected to decrease by 8.03% this quarter, and institutional views are bullish

Earnings Agent
·
May 04

Harrow updates financial calendar with upcoming quarterly results release and conference call

Reuters
·
Apr 27

Harrow announces annual shareholder meeting

Reuters
·
Apr 25

Harrow Price Target Maintained With a $63.00/Share by BTIG

Dow Jones
·
Apr 17

Analysts Offer Insights on Healthcare Companies: Harrow Health (HROW) and BioCryst (BCRX)

TIPRANKS
·
Apr 16

Harrow announces issuance of J-Code for Iopidine 1%

TIPRANKS
·
Apr 16

Harrow Inc - Iopidine 1% Assigned Permanent J-Code J2374 by CMS Effective July 1, 2026

THOMSON REUTERS
·
Apr 16